News Release(2011)

December 12, 2011

Transfer of Distribution Rights for Antiparkinson's Disease Agent "CABASER® Tab. 0.25mg・1.0mg"

September 1, 2011

Acquisition of development and marketing right of "Dexrazoxane" for the Treatment of Anthracycline Extravasation in Japan

July 21, 2011

Announcement for launching GLUBES® in Japan - Fixed dose combination tablet of a rapid-acting insulin secretagogue and improving agent for postprandial hyperglycemia

April 22, 2011

New Drug Application Approval for GLUBES® - Fixed dose combination tablet of a rapid-acting insulin secretagogue and improving agent for postprandial hyperglycemia